Personalised Medicine Market Size, Share, Trends & Forecast 2026–2034

Table of Contents

1. Introduction

    1.1 Report Scope and Market Definition

        1.1.1 Personalised Medicine — Definition and Scope

        1.1.2 Inclusions and Exclusions

        1.1.3 Key Assumptions

    1.2 Research Objectives

    1.3 Market Stakeholders and Target Audience

    1.4 Abbreviations and Acronyms

 

2. Research Methodology

    2.1 Research Approach Overview

    2.2 Primary Research

        2.2.1 Stakeholders Consulted

        2.2.2 Primary Data Collection Process

    2.3 Secondary Research

        2.3.1 Secondary Sources Reviewed

        2.3.2 Data Extraction and Validation

    2.4 Market Sizing and Forecast Methodology

        2.4.1 Bottom-Up Approach

        2.4.2 Top-Down Approach

        2.4.3 Data Triangulation and Quality Assurance

    2.5 Report Limitations and Disclaimers

 

3. Executive Summary

    3.1 Global Personalised Medicine Market Snapshot

    3.2 Key Market Highlights

    3.3 Dominant Segments at a Glance

    3.4 Regional Snapshot

    3.5 Competitive Summary

 

4. Market Dynamics

    4.1 Market Drivers

        4.1.1 Genomic Sequencing Cost Compression

        4.1.2 Companion Diagnostic Regulatory Momentum

        4.1.3 Cell & Gene Therapy Commercial Maturation

        4.1.4 AI and Digital Health Platform Integration

    4.2 Market Restraints

        4.2.1 Reimbursement Fragmentation Across Major Markets

        4.2.2 Data Privacy and Biosecurity Regulatory Complexity

        4.2.3 Manufacturing Scalability Constraints for Cell & Gene Therapies

    4.3 Market Opportunities

        4.3.1 Pharmacogenomics Integration in Chronic Disease Management

        4.3.2 Liquid Biopsy Market Expansion Beyond Oncology

        4.3.3 Rare Disease Gene Therapy Pipeline Monetisation

        4.3.4 AI-Powered Multi-Omic Data Platforms

    4.4 Market Challenges

        4.4.1 Health Equity and Genomic Access Disparities

        4.4.2 Genomic Data Interoperability and Clinical Integration

        4.4.3 Reimbursement Model Evolution Lag

 

5. Personalised Medicine Market — By Therapy Area

    5.1 Overview and Therapy Area Comparison

    5.2 Oncology — Market Sizing, Drivers, and Forecast

    5.3 Cardiology — Market Sizing, Drivers, and Forecast

    5.4 Neurology — Market Sizing, Drivers, and Forecast

    5.5 Rare Diseases — Market Sizing, Drivers, and Forecast

    5.6 Others — Market Sizing and Forecast

 

6. Personalised Medicine Market — By Technology

    6.1 Overview and Technology Comparison

    6.2 Genomics & Proteomics — Market Sizing, Drivers, and Forecast

    6.3 Companion Diagnostics — Market Sizing, Drivers, and Forecast

    6.4 Precision Diagnostics — Market Sizing, Drivers, and Forecast

    6.5 Digital Health & AI — Market Sizing, Drivers, and Forecast

    6.6 Others — Market Sizing and Forecast

 

7. Personalised Medicine Market — By Drug Type

    7.1 Overview and Drug Type Comparison

    7.2 Small Molecules — Market Sizing, Drivers, and Forecast

    7.3 Biologics — Market Sizing, Drivers, and Forecast

    7.4 Cell & Gene Therapies — Market Sizing, Drivers, and Forecast

    7.5 Others — Market Sizing and Forecast

 

8. Personalised Medicine Market — By End User

    8.1 Overview and End User Comparison

    8.2 Hospitals & Clinics — Market Sizing, Drivers, and Forecast

    8.3 Diagnostic Laboratories — Market Sizing, Drivers, and Forecast

    8.4 Research Institutes — Market Sizing, Drivers, and Forecast

    8.5 Pharmaceutical Companies — Market Sizing, Drivers, and Forecast

    8.6 Others — Market Sizing and Forecast

 

9. Regional Analysis

    9.1 Global Personalised Medicine Market — Regional Overview

    9.2 North America Personalised Medicine Market

        9.2.1 North America Market Overview

        9.2.2 The U.S. Personalised Medicine Market

        9.2.3 Canada Personalised Medicine Market

        9.2.4 Mexico Personalised Medicine Market

    9.3 Europe Personalised Medicine Market

        9.3.1 Europe Market Overview

        9.3.2 Germany | 9.3.3 France | 9.3.4 U.K.

        9.3.5 Italy | 9.3.6 Spain | 9.3.7 Russia

        9.3.8 BENELUX | 9.3.9 Sweden | 9.3.10 Denmark

        9.3.11 Poland | 9.3.12 Austria | 9.3.13 Rest of Europe

    9.4 Asia Pacific Personalised Medicine Market

        9.4.1 Asia Pacific Market Overview

        9.4.2 China | 9.4.3 Japan | 9.4.4 India

        9.4.5 South Korea | 9.4.6 Australia | 9.4.7 Thailand

        9.4.8 Indonesia | 9.4.9 Vietnam | 9.4.10 Malaysia

        9.4.11 Philippines | 9.4.12 Taiwan | 9.4.13 Rest of Asia Pacific

    9.5 Latin America Personalised Medicine Market

        9.5.1 Latin America Market Overview

        9.5.2 Brazil | 9.5.3 Argentina | 9.5.4 Colombia

        9.5.5 Chile | 9.5.6 Peru | 9.5.7 Rest of Latin America

    9.6 The Middle East Personalised Medicine Market

        9.6.1 The Middle East Market Overview

        9.6.2 GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman)

        9.6.3 Israel | 9.6.4 Turkey | 9.6.5 Iran | 9.6.6 Rest of The Middle East

    9.7 Africa Personalised Medicine Market

        9.7.1 Africa Market Overview

        9.7.2 South Africa | 9.7.3 Egypt | 9.7.4 Nigeria

        9.7.5 Algeria | 9.7.6 Morocco | 9.7.7 Rest of Africa

 

10. Competitive Landscape

    10.1 Market Concentration and Fragmentation Analysis

    10.2 Competitive Positioning Map

    10.3 Key Strategies Adopted by Market Leaders

    10.4 Mergers, Acquisitions, and Strategic Partnerships

    10.5 New Product Launches and Innovations

 

11. Company Profiles

    11.1 Roche Holdings AG — Overview, Products, Revenue, Recent Developments

    11.2 Novartis AG — Overview, Products, Revenue, Recent Developments

    11.3 Pfizer Inc. — Overview, Products, Revenue, Recent Developments

    11.4 Illumina Inc. — Overview, Products, Revenue, Recent Developments

    11.5 Thermo Fisher Scientific Inc. — Overview, Products, Revenue, Recent Developments

    11.6 Foundation Medicine Inc. — Overview, Products, Revenue, Recent Developments

    11.7 QIAGEN N.V. — Overview, Products, Revenue, Recent Developments

    11.8 AstraZeneca plc — Overview, Products, Revenue, Recent Developments

    11.9 Merck & Co. Inc. — Overview, Products, Revenue, Recent Developments

    11.10 Johnson & Johnson — Overview, Products, Revenue, Recent Developments

    11.11 Guardant Health Inc. — Overview, Products, Revenue, Recent Developments

    11.12 Pacific Biosciences of California Inc. — Overview, Products, Recent Developments

    11.13 Genomic Health Inc. — Overview, Products, Revenue, Recent Developments

    11.14 Blueprint Medicines Corporation — Overview, Products, Recent Developments

    11.15 Exact Sciences Corporation — Overview, Products, Revenue, Recent Developments

 

12. Recent Developments and Strategic Moves

    12.1 Mergers and Acquisitions

    12.2 Product Launches

    12.3 Regulatory Approvals and Policy Changes

    12.4 Strategic Partnerships and Collaborations

    12.5 Investments and Capacity Expansions

 

13. Future Outlook and Forecast Summary

    13.1 Personalised Medicine Market Size Forecast, 2026–2034

    13.2 Segment Forecast Summary

    13.3 Regional Forecast Summary

    13.4 Scenario Analysis (Conservative, Base, Optimistic)

    13.5 Key Success Factors and Strategic Recommendations

 

14. Appendix

    14.1 Research Methodology Detail

    14.2 List of Primary Research Participants (Anonymised)

    14.3 Data Sources

    14.4 Glossary of Terms

    14.5 About Zion Market Research

List of Tables

Table 1: Global Personalised Medicine Market Size, USD Mn, 2019–2034

Table 2: Personalised Medicine Market by Therapy Area, USD Mn, 2019–2034

Table 3: Personalised Medicine Market by Technology, USD Mn, 2019–2034

Table 4: Personalised Medicine Market by Drug Type, USD Mn, 2019–2034

Table 5: Personalised Medicine Market by End User, USD Mn, 2019–2034

Table 6: North America Personalised Medicine Market by Country, USD Mn, 2019–2034

Table 7: Europe Personalised Medicine Market by Country, USD Mn, 2019–2034

Table 8: Asia Pacific Personalised Medicine Market by Country, USD Mn, 2019–2034

Table 9: Latin America Personalised Medicine Market by Country, USD Mn, 2019–2034

Table 10: The Middle East Personalised Medicine Market by Country, USD Mn, 2019–2034

Table 11: Africa Personalised Medicine Market by Country, USD Mn, 2019–2034

Table 12: Key Companies — Revenue Estimates and Market Share, 2025

Table 13: Competitive Strategy Matrix — 15 Leading Players

Table 14: Recent Developments Summary Table, 2023–2025

Table 15: Personalised Medicine Market CAGR by Segment, 2026–2034

 

List of Figures

Figure 1: Global Personalised Medicine Market Size and Forecast, USD Mn, 2019–2034

Figure 2: Personalised Medicine Market Share by Therapy Area, 2025

Figure 3: Personalised Medicine Market Share by Technology, 2025

Figure 4: Personalised Medicine Market Share by Drug Type, 2025

Figure 5: Personalised Medicine Market Share by End User, 2025

Figure 6: Personalised Medicine Market Share by Region, 2025

Figure 7: DROC Analysis — Personalised Medicine Market Dynamics

Figure 8: North America Personalised Medicine Market Size, 2019–2034

Figure 9: Asia Pacific Personalised Medicine Market Size, 2019–2034

Figure 10: Competitive Positioning Map — Personalised Medicine Market